Literature DB >> 23649889

Mild therapeutic hypothermia after out-of-hospital cardiac arrest complicating ST-elevation myocardial infarction: long-term results in clinical practice.

Stefan Zimmermann1, Frank A Flachskampf, Reinhard Schneider, Katharina Dechant, Anna Alff, Lutz Klinghammer, Harald Rittger, Stephan Achenbach.   

Abstract

BACKGROUND: Recently, mild therapeutic hypothermia (MTH) has been integrated into the European resuscitation guidelines to improve outcomes after out-of-hospital cardiac arrest (OHCA). Data on long-term results are limited, especially in patients with acute ST-elevation myocardial infarction (STEMI). HYPOTHESIS: Invasive MTH influences long-term prognosis after OHCA due to STEMI.
METHODS: We analyzed 48 patients who underwent emergency coronary angiography for STEMI after witnessed OHCA. In 24 consecutive patients, MTH was performed via intravascular cooling (CoolGard System, 34°C maintained for 24 hours) after initialization by rapid infusion of cold saline. Clinical, procedural, and mortality data were compared to 24 historical controls. Neurological recovery was assessed using the Cerebral Performance Category score (CPC) at 30-day and 1-year follow-up.
RESULTS: Median time delay until arrival of emergency medical service was 6 minutes (MTH group) vs 6.5 minutes (controls) (P = 0.16). Initial rhythm was ventricular fibrillation in 75% vs 66.7% (P = 0.75). There were no differences regarding baseline characteristics, angiographic findings, and success of cardiac catheterization procedures. MTH was not associated with a higher frequency of bleeding complications or of pneumonia. Thirty-day mortality was 33.3% in both groups. One-year mortality was 37.5% (MTH group) vs 50% (controls) (P = 0.56). At 1 year, favorable neurological outcome (CPC ≤2) was significantly more frequent in the MTH group (58.3% vs 20.8%, P = 0.017). Multivariate analysis identified MTH as independent predictor of favorable neurological outcome (P < 0.02, odds ratio: 12.73).
CONCLUSIONS: MTH via intravascular cooling improves neurological long-term prognosis after OHCA due to STEMI and is safe in clinical practice.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649889      PMCID: PMC6649379          DOI: 10.1002/clc.22131

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  6 in total

Review 1.  Invasive strategy in patients with resuscitated cardiac arrest and ST elevation myocardial infarction.

Authors:  Vojka Gorjup; Marko Noc; Peter Radsel
Journal:  World J Cardiol       Date:  2014-06-26

2.  Mechanical Chest Compressions in Prolonged Cardiac Arrest due to ST Elevation Myocardial Infarction Can Cause Myocardial Contusion.

Authors:  Cyril Stechovsky; Petr Hajek; Simon Cipro; Josef Veselka
Journal:  Int J Angiol       Date:  2015-01-12

3.  Using vascular closure devices following out-of-hospital cardiac arrest?

Authors:  Martin Christ; Katharina Isabel von Auenmueller; Jeanette Liebeton; Martin Grett; Wolfgang Dierschke; Jan Peter Noelke; Irini Maria Breker; Hans-Joachim Trappe
Journal:  Int J Med Sci       Date:  2015-03-28       Impact factor: 3.738

4.  Study on the priority of coronary arteriography or therapeutic hypothermia after return of spontaneous circulation in patients with out-of-hospital cardiac arrest: results from the SOS-KANTO 2012 study.

Authors:  Shuichi Hagiwara
Journal:  Intern Emerg Med       Date:  2016-02-01       Impact factor: 3.397

5.  Predictors of Mortality in Patients with ST-Segment Elevation Acute Myocardial Infarction and Resuscitated Out-of-Hospital Cardiac Arrest.

Authors:  Andreea Bărcan; Monica Chițu; Edvin Benedek; Nora Rat; Szilamer Korodi; Mirabela Morariu; Istvan Kovacs
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09

Review 6.  Contemporary Management of Out-of-hospital Cardiac Arrest in the Cardiac Catheterisation Laboratory: Current Status and Future Directions.

Authors:  Nilesh Pareek; Peter Kordis; Ian Webb; Marko Noc; Philip MacCarthy; Jonathan Byrne
Journal:  Interv Cardiol       Date:  2019-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.